fbpx

ADVERTISEMENT

ADVERTISEMENT

Gonorrhea

Updated : October 3, 2022





Background

Neisseria gonorrhoeae causes Gonnorhea, a sexually transmitted infection that causes significant global morbidity in developed and developing nations. Like other STIs, gonorrhea disproportionately affects young adult populations.

Epidemiology

N. gonorrhoeae is the world’s second most prevalent source of bacterial sexually transmitted infections. The WHO estimated 106 million cases recorded among adults globally each year, with many more infections going undetected. With almost 5,00,000 instances reported each year in the United States alone.

Gonorrhea infection has a significant male predominance due to the higher possibility that males may experience urogenital symptoms and an increase in diagnoses among gay men. The emergence of antibiotic-resistant strains has increased the prevalence of gonorrheal STIs during the previous decade.

Anatomy

Pathophysiology

The infection of N. gonorrhoeae begins with gonococcal adherence to epithelial cells, accompanied by the local cellular intrusion. Gonorrhea possesses several surface proteins that aid in adherence. N. gonorrhoeae uses pili to establish an attachment to epithelial cells. Pili are hair-like appendages that coat the bacterial surface.

Because of their capacity to extend and retract, bacteria can adhere from a distance and migrate closer to epithelial cells, facilitating cellular invasion. Pili also helps with mobility and protection. Lipooligosaccharide binds to sperm cells, resulting in transfer from infected men to uninfected sexual partners.

Bacterial cells interact with host cell component receptors type 3 during the invasion of the cervical epithelium. The attachment of pili to the CR3 initiates this communication. Ruffling permits gonococci to infiltrate host cells in the form of giant vacuoles known as macropinosomes and proliferate within infected cells.

Gonococci are classified as serum-resistant or serum-sensitive depending on their susceptibility to complement activation death; serum-resistant strains can cause disseminated infection. N. gonorrhoeae has evolved a few methods to counteract the immunological defenses of its hosts’ adaptive and innate immunity systems.

Etiology

In nature, the obligatory pathogen N. gonorrhoeae only infects humans and causes urethritis in males and cervicitis in females. Bacteria exhibit symptoms to spread from one host to the other. These bacteria must infect a host to exist; they cannot survive without a host.

Untreated and undiagnosed gonorrheal urogenital infections can spread through the upper genitourinary tract and cause various severe reproductive complications, most commonly but not primarily in women, including endometritis, pelvic inflammatory disease, infertility, or life-threatening mortality through an ectopic pregnancy.

Genetics

Prognostic Factors

Antibiotics can generally treat a gonorrhea infection that has not spread. Antimicrobial resistance increases the mortality rate.

Clinical History

Physical Examination

Age group

Associated comorbidity

Associated activity

Acuity of presentation

Differential Diagnoses

Laboratory Studies

Imaging Studies

Procedures

Histologic Findings

Staging

Treatment Paradigm

by Stage

by Modality

Chemotherapy

Radiation Therapy

Surgical Interventions

Hormone Therapy

Immunotherapy

Hyperthermia

Photodynamic Therapy

Stem Cell Transplant

Targeted Therapy

Palliative Care

Medication

 

cefixime 

Indicated for Uncomplicated Gonorrhea:


400 mg orally once along with azithromycin 1g orally once or doxycycline
100mg orally every 12hhr for 7days as alternate therapy



tetracycline 

500 mg of tetracycline orally every 6 hours for 7 days



probenecid 

Administer 1 gram orally along with a single 2-gram dose of cefoxitin intramuscularly



sultamicillin 

Take a single dose of 2.25 g orally in combination with probenecid



spiramycin 

8-9 capsules (12,000,000-13,500,000 units) of Rovamycine 500 orally administered as one dose
Note: spiramycin is not advised as a suitable treatment for gonorrhea according to clinical practice guidelines



 

probenecid 

For individuals weighing over 45 kg, an oral dose of 1 gram and a single intramuscular dose of 2 grams of cefoxitin should be administered



 

Media Gallary

References

https://www.ncbi.nlm.nih.gov/books/NBK558903/

ADVERTISEMENT 

Gonorrhea

Updated : October 3, 2022




Neisseria gonorrhoeae causes Gonnorhea, a sexually transmitted infection that causes significant global morbidity in developed and developing nations. Like other STIs, gonorrhea disproportionately affects young adult populations.

N. gonorrhoeae is the world’s second most prevalent source of bacterial sexually transmitted infections. The WHO estimated 106 million cases recorded among adults globally each year, with many more infections going undetected. With almost 5,00,000 instances reported each year in the United States alone.

Gonorrhea infection has a significant male predominance due to the higher possibility that males may experience urogenital symptoms and an increase in diagnoses among gay men. The emergence of antibiotic-resistant strains has increased the prevalence of gonorrheal STIs during the previous decade.

The infection of N. gonorrhoeae begins with gonococcal adherence to epithelial cells, accompanied by the local cellular intrusion. Gonorrhea possesses several surface proteins that aid in adherence. N. gonorrhoeae uses pili to establish an attachment to epithelial cells. Pili are hair-like appendages that coat the bacterial surface.

Because of their capacity to extend and retract, bacteria can adhere from a distance and migrate closer to epithelial cells, facilitating cellular invasion. Pili also helps with mobility and protection. Lipooligosaccharide binds to sperm cells, resulting in transfer from infected men to uninfected sexual partners.

Bacterial cells interact with host cell component receptors type 3 during the invasion of the cervical epithelium. The attachment of pili to the CR3 initiates this communication. Ruffling permits gonococci to infiltrate host cells in the form of giant vacuoles known as macropinosomes and proliferate within infected cells.

Gonococci are classified as serum-resistant or serum-sensitive depending on their susceptibility to complement activation death; serum-resistant strains can cause disseminated infection. N. gonorrhoeae has evolved a few methods to counteract the immunological defenses of its hosts’ adaptive and innate immunity systems.

In nature, the obligatory pathogen N. gonorrhoeae only infects humans and causes urethritis in males and cervicitis in females. Bacteria exhibit symptoms to spread from one host to the other. These bacteria must infect a host to exist; they cannot survive without a host.

Untreated and undiagnosed gonorrheal urogenital infections can spread through the upper genitourinary tract and cause various severe reproductive complications, most commonly but not primarily in women, including endometritis, pelvic inflammatory disease, infertility, or life-threatening mortality through an ectopic pregnancy.

Antibiotics can generally treat a gonorrhea infection that has not spread. Antimicrobial resistance increases the mortality rate.

cefixime 

Indicated for Uncomplicated Gonorrhea:


400 mg orally once along with azithromycin 1g orally once or doxycycline
100mg orally every 12hhr for 7days as alternate therapy



tetracycline 

500 mg of tetracycline orally every 6 hours for 7 days



probenecid 

Administer 1 gram orally along with a single 2-gram dose of cefoxitin intramuscularly



sultamicillin 

Take a single dose of 2.25 g orally in combination with probenecid



spiramycin 

8-9 capsules (12,000,000-13,500,000 units) of Rovamycine 500 orally administered as one dose
Note: spiramycin is not advised as a suitable treatment for gonorrhea according to clinical practice guidelines



probenecid 

For individuals weighing over 45 kg, an oral dose of 1 gram and a single intramuscular dose of 2 grams of cefoxitin should be administered



https://www.ncbi.nlm.nih.gov/books/NBK558903/

Free CME credits

Both our subscription plans include Free CME/CPD AMA PRA Category 1 credits.

Digital Certificate PDF

On course completion, you will receive a full-sized presentation quality digital certificate.

medtigo Simulation

A dynamic medical simulation platform designed to train healthcare professionals and students to effectively run code situations through an immersive hands-on experience in a live, interactive 3D environment.

medtigo Points

medtigo points is our unique point redemption system created to award users for interacting on our site. These points can be redeemed for special discounts on the medtigo marketplace as well as towards the membership cost itself.
 
  • Registration with medtigo = 10 points
  • 1 visit to medtigo’s website = 1 point
  • Interacting with medtigo posts (through comments/clinical cases etc.) = 5 points
  • Attempting a game = 1 point
  • Community Forum post/reply = 5 points

    *Redemption of points can occur only through the medtigo marketplace, courses, or simulation system. Money will not be credited to your bank account. 10 points = $1.

All Your Certificates in One Place

When you have your licenses, certificates and CMEs in one place, it's easier to track your career growth. You can easily share these with hospitals as well, using your medtigo app.

Our Certificate Courses